Royal College of Pathologists
Amy Spivey serves as the Examinations Operations Manager at the Royal College of Pathologists since January 2023, and has held the position of Examinations Manager at the Royal College of Emergency Medicine since August 2015. In these roles, Amy manages the operational delivery of high-stakes examinations, specifically the MRCEM and FRCEM Objective Structured Clinical Examinations (OSCE), ensuring quality service for candidates both in the UK and internationally. Amy's previous experience includes positions as Examinations Officer and Examinations Administrator at Lewisham College and Southwark College, where responsibilities involved managing examination processes and candidate registrations. Amy's early career included being a Data Specialist with Bermondesy and Lansdowne Medical Mission. Academic qualifications include A-levels from the City of London Academy and a degree in Law from the University of Greenwich.
This person is not in any offices
Royal College of Pathologists
1 followers
Pathology is the science at the heart of modern medicine, vital for the diagnosis and clinical management of disease. It is the science behind the cure, or the hidden science that saves lives. Although some pathologists work in laboratories, many work directly with patients in hospitals and the community. Together they are involved in over 70% of all diagnoses, as well as playing an important role in disease prevention, treatment and monitoring. The College is a professional membership organisation committed to setting and maintaining professional standards and to promoting excellence in the practice of pathology. The College aims to advance the science and practice of pathology, to provide public education, to promote research in pathology and to disseminate the results. It is a registered charity. The College was founded in 1962 and received its Royal Charter in 1970. There are 11,000 members worldwide practicing in the 19 pathology specialties. Approximately 78% of the membership are medically qualified, with the remaining 22% being senior clinical scientists.